0001104659-18-042932.txt : 20180628
0001104659-18-042932.hdr.sgml : 20180628
20180628180645
ACCESSION NUMBER: 0001104659-18-042932
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180627
FILED AS OF DATE: 20180628
DATE AS OF CHANGE: 20180628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McLaughlin Gerald W.
CENTRAL INDEX KEY: 0001495412
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37508
FILM NUMBER: 18926602
MAIL ADDRESS:
STREET 1: 227 WASHINGTON STREET
STREET 2: SUITE 200
CITY: CONSHOHOCKEN
STATE: PA
ZIP: 19428
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Neos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001467652
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270395455
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2940 N. HIGHWAY 360
STREET 2: SUITE 400
CITY: GRAND PRAIRIE
STATE: TX
ZIP: 75050
BUSINESS PHONE: 972.408.1360
MAIL ADDRESS:
STREET 1: 2940 N. HIGHWAY 360
STREET 2: SUITE 400
CITY: GRAND PRAIRIE
STATE: TX
ZIP: 75050
4
1
a4.xml
4
X0306
4
2018-06-27
0
0001467652
Neos Therapeutics, Inc.
NEOS
0001495412
McLaughlin Gerald W.
C/O NEOS THERAPEUTICS, INC.
2940 N. HWY 360
GRAND PRAIRIE
TX
75050
1
1
0
0
Chief Executive Officer
Stock Option (Right to Buy)
6.20
2018-06-27
4
A
0
600000
0
A
2028-06-27
Common Stock
600000
600000
D
This stock option was granted pursuant to the Company's 2018 Inducement Plan and vests in equal annual installments over a four-year period which began on June 27, 2018.
/s/ Richard Eisenstadt, attorney in fact
2018-06-28